Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Faucher

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Bulletin Du Cancer|October 22, 2021
[Ethics and societies: Crossed views]Jacques-Olivier Bay, Catherine Faucher
Medecine Sciences : M/S|July 13, 2010
[Happy birthday to Joint Accreditation Committee for ISCT Europe and EBMT]Olivia Caunday, Catherine Faucher, Noël Milpied, et al.
Haematologica|May 10, 2007
Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemiaDidier Blaise, Norbert Vey, Catherine Faucher, et al.
Hematology (Amsterdam, Netherlands)|September 29, 2005
Current update on reduced intensity regimens for allogeneic stem cell transplantationDidier Blaise, Mohamad Mohty, Catherine Faucher, et al.
La Revue Du Praticien|October 23, 2025
[Agence de la biomédecine: twenty years of combining ethics and innovation]Marine Jeantet, Anne Debeaumont, Catherine Faucher, et al.
Haematologica|July 4, 2007
Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Odile Avinens, Catherine Faucher, et al.
Journal of Medical Virology|January 26, 2011
Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantationPhilippe Halfon, Pierre Berger, Hacene Khiri, et al.
Haematologica|September 12, 2006
Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationHugues de Lavallade, Mohamad Mohty, Catherine Faucher, et al.
Bulletin Du Cancer|November 13, 2017
[HLA coding in ProMISe: Guidelines from the Francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]Nicole Raus, Catherine Faucher, Anne Kennel, et al.
Critical Care (London, England)|March 16, 2007
N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shockDjamel Mokart, Antoine Sannini, Jean-Paul Brun, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Bulletin Du Cancer|October 22, 2021
[Ethics and societies: Crossed views]Jacques-Olivier Bay, Catherine Faucher
Medecine Sciences : M/S|July 13, 2010
[Happy birthday to Joint Accreditation Committee for ISCT Europe and EBMT]Olivia Caunday, Catherine Faucher, Noël Milpied, et al.
Haematologica|May 10, 2007
Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemiaDidier Blaise, Norbert Vey, Catherine Faucher, et al.
Hematology (Amsterdam, Netherlands)|September 29, 2005
Current update on reduced intensity regimens for allogeneic stem cell transplantationDidier Blaise, Mohamad Mohty, Catherine Faucher, et al.
La Revue Du Praticien|October 23, 2025
[Agence de la biomédecine: twenty years of combining ethics and innovation]Marine Jeantet, Anne Debeaumont, Catherine Faucher, et al.
Haematologica|July 4, 2007
Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Odile Avinens, Catherine Faucher, et al.
Journal of Medical Virology|January 26, 2011
Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantationPhilippe Halfon, Pierre Berger, Hacene Khiri, et al.
Haematologica|September 12, 2006
Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationHugues de Lavallade, Mohamad Mohty, Catherine Faucher, et al.
Bulletin Du Cancer|November 13, 2017
[HLA coding in ProMISe: Guidelines from the Francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]Nicole Raus, Catherine Faucher, Anne Kennel, et al.
Critical Care (London, England)|March 16, 2007
N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shockDjamel Mokart, Antoine Sannini, Jean-Paul Brun, et al.
Pageof 8